|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kim TH and Shivdasani RA: Stomach
development, stem cells and disease. Development. 143:554–565.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Han X, Wang X, Zhao B, Chen G, Sheng Y,
Wang W and Teng M: MicroRNA-187 inhibits tumor growth and
metastasis via targeting of IGF-1R in hepatocellular carcinoma. Mol
Med Rep. 16:2241–2246. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hou R, Wang D and Lu J: MicroRNA-10b
inhibits proliferation, migration and invasion in cervical cancer
cells via direct targeting of insulin-like growth factor-1
receptor. Oncol Lett. 13:5009–5015. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lu S, Wang MS, Chen PJ, Ren Q and Bai P:
miRNA-186 inhibits prostate cancer cell proliferation and tumor
growth by targeting YY1 and CDK6. Exp Ther Med. 13:3309–3314. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li Q, Li Z, Wei S, Wang W, Chen Z, Zhang
L, Chen L, Li B, Sun G, Xu J, et al: Overexpression of miR-584-5p
inhibits proliferation and induces apoptosis by targeting WW
domain-containing E3 ubiquitin protein ligase 1 in gastric cancer.
J Exp Clin Cancer Res. 36:592017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wu F, Li J, Guo N, Wang XH and Liao YQ:
miRNA-27a promotes the proliferation and invasion of human gastric
cancer MGC803 cells by targeting SFRP1 via Wnt/β-catenin signaling
pathway. Am J Cancer Res. 7:405–416. 2017.PubMed/NCBI
|
|
8
|
Huang X and Lu S: MicroR-545 mediates
colorectal cancer cells proliferation through up-regulating
epidermal growth factor receptor expression in HOTAIR long
non-coding RNA dependent. Mol Cell Biochem. 431:45–54. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tamaddon G, Geramizadeh B, Karimi MH,
Mowla SJ and Abroun S: miR-4284 and miR-4484 as putative biomarkers
for diffuse large B-cell lymphoma. Iran J Med Sci. 41:334–339.
2016.PubMed/NCBI
|
|
10
|
Yang F, Nam S, Brown CE, Zhao R, Starr R,
Ma Y, Xie J, Horne DA, Malkas LH, Jove R and Hickey RJ: A novel
berbamine derivative inhibits cell viability and induces apoptosis
in cancer stem-like cells of human glioblastoma, via up-regulation
of miRNA-4284 and JNK/AP-1 signaling. PLoS One. 9:e944432014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang L, Yu SJ, Hong Q, Yang Y and Zhao ZM:
Reduced expression of TET1, TET2, TET3 and TDG mRNAs are associated
with poor prognosis of patients with early breast cancer. PLoS One.
10:e01338962015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fan M, He X and Xu X: Restored expression
levels of TET1 decrease the proliferation and migration of renal
carcinoma cells. Mol Med Rep. 12:4837–4842. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Neri F, Dettori D, Incarnato D, Krepelova
A, Rapelli S, Maldotti M, Parlato C, Paliogiannis P and Oliviero S:
TET1 is a tumour suppressor that inhibits colon cancer growth by
derepressing inhibitors of the WNT pathway. Oncogene. 34:4168–4176.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang W, Lu Z, Gao Y, Ye L, Song T and
Zhang X: miR-520b suppresses proliferation of hepatoma cells
through targeting ten-eleven translocation 1 (TET1) mRNA. Biochem
Biophys Res Commun. 460:793–798. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pei YF, Lei Y and Liu XQ: miR-29a promotes
cell proliferation and EMT in breast cancer by targeting ten eleven
translocation 1. Biochim Biophys Acta. 1862:2177–2185. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang B, Shen ZL, Jiang KW, Zhao G, Wang
CY, Yan YC, Yang Y, Zhang JZ, Shen C, Gao ZD, et al: MicroRNA-217
functions as a prognosis predictor and inhibits colorectal cancer
cell proliferation and invasion via an AEG-1 dependent mechanism.
BMC Cancer. 15:4372015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ang TL, Khor CJ and Gotoda T: Diagnosis
and endoscopic resection of early gastric cancer. Singapore Med J.
51:93–100. 2010.PubMed/NCBI
|
|
18
|
Gu H, Yang T, Fu S, Chen X, Guo L and Ni
Y: MicroRNA-490-3p inhibits proliferation of A549 lung cancer cells
by targeting CCND1. Biochem Biophys Res Commun. 444:104–108. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li N, Miao Y, Shan Y, Liu B, Li Y, Zhao L
and Jia L: miR-106b and miR-93 regulate cell progression by
suppression of PTEN via PI3K/Akt pathway in breast cancer. Cell
Death Dis. 8:e27962017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang B, Wu H, Chai C, Lewis J, Pichiorri
F, Eisenstat DD, Pomeroy SL and Leng RP: MicroRNA-1301 suppresses
tumor cell migration and invasion by targeting the p53/UBE4B
pathway in multiple human cancer cells. Cancer Lett. 401:20–32.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Eccles SA and Welch DR: Metastasis: Recent
discoveries and novel treatment strategies. Lancet. 369:1742–1757.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Peter ME: Targeting of mRNAs by multiple
miRNAs: The next step. Oncogene. 29:2161–2164. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fu HL, Ma Y, Lu LG, Hou P, Li BJ, Jin WL
and Cui DX: TET1 exerts its tumor suppressor function by
interacting with p53-EZH2 pathway in gastric cancer. J Biomed
Nanotechnol. 10:1217–1230. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Frycz BA, Murawa D, Borejsza-Wysocki M,
Marciniak R, Murawa P, Drews M, Kołodziejczak A, Tomela K and
Jagodziński PP: Decreased expression of ten-eleven translocation 1
protein is associated with some clinicopathological features in
gastric cancer. Biomed Pharmacother. 68:209–212. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pei YF, Tao R, Li JF, Su LP, Yu BQ, Wu XY,
Yan M, Gu QL, Zhu ZG and Liu BY: TET1 inhibits gastric cancer
growth and metastasis by PTEN demethylation and re-expression.
Oncotarget. 7:31322–31335. 2016. View Article : Google Scholar : PubMed/NCBI
|
